CAPPI: Evaluation of the "Pupillary Pain Index" in Neurological Prognosis After Cardiac Arrest

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04336930
Collaborator
(none)
60
19.9

Study Details

Study Description

Brief Summary

Two-thirds of patients admitted to the Intensive Care Unit after a cardiac arrest die in the context of treatment withdrawal after a multimodal evaluation that determines an unfavorable neurological outcome.

This study will evaluate the Pupillary Pain Index (PPI) in the neurological prognosis after cardiac arrest. The PPI is determined by recording of pupillary dilatation with a videopupillometer after a calibrated and incremented nociceptive stimulus on a cutaneous metamere.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Pupillary pain index (PPI)

Detailed Description

Cardiorespiratory arrest is associated with high mortality and morbidity rates. The direct consequence of a cardio-circulatory arrest is the absence of blood flow allowing oxygenation of the organs and consequently formation of ischemic lesions. Anoxic cerebral lesions are common in the aftermath of a cardiac arrest and often lead to the death of patients when active therapies are stopped after a multimodal prognostication that indicates that a poor outcome is very likely.

It is of paramount importance to optimize the sensitivity of the prognostication strategy in detecting good neurological outcome. A multimodal approach to the prognostic assessment is essential, and must include at least clinical examination, electrophysiology exploration (electroencephalography and/or evoked potentials) and biomarker analysis.

Although the most reliable predictors did not give false positives in most studies, none of them, considered individually, can establish an unfavorable prognosis with an absolute degree of certitude. For these reasons it is interesting to evaluate new prognostication tools.

The videopupillometry allows precise, reproducible and repeated measurement of changes in pupil diameter in response to a painful or a luminous stimulus. Pupillary pain reflex analysis is usually used to assess the degree of analgesia in a non-communicative patient during general anesthesia and neuromuscular blockade. The PPI score is determined at the bedside by recording pupillary dilatation after a calibrated and incremented nociceptive stimulus (electrical current between 5 and 60mA) applied to a skin metamere with two electrodes.

Automated pupillometry measurement has been recently developed to help support prognostication, with a quantitative pupillary light reflex measurement. The aim of this study is to evaluate the Pupillary Pain Index in the neurological prognosis after a cardiac arrest by correlating the PPI at 48h from the patient's arrival to the CPC score at 3 months.

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of the Pupillary Dilatation Reflex With the "Pupillary Pain Index" in Neurological Prognosis After Cardiac Arrest
Anticipated Study Start Date :
Nov 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Jul 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Cardiac Arrest group

Patients remaining comatose after a cardiac arrest

Diagnostic Test: Pupillary pain index (PPI)
Measurement of PPI with a pupillometer

Outcome Measures

Primary Outcome Measures

  1. Score Cerebral Performance Category (CPC) [3 months]

    Good outcome defined as CPC 1-2, poor outcome defined as CPC 3-5

Secondary Outcome Measures

  1. Characteristics of electroencephalography pattern [Day 2, day 3, day 5, day 7]

    Classification of Synek, type of pattern (Very malignant, malignant or benign)

  2. Biomarkers [24 hours, 48 hours]

    Value of seric Neuron Specific Enolase

  3. Glasgow motor score [24 hours, 48 hours, day 5, day 7]

    Motor response component of the Glasgow Coma Scale, ranging from 1 (no response) to 6 (normal response)

  4. ICU parameters [Day 14]

    Ventilator days, Length of stay

  5. Evoked Potentials [Day 14]

    Presence or absence of the N20 component of the evoked potentials

  6. Neurological pupil index [Day 2, day 3]

    standardized evaluation of pupil reactivity ranging from 0 (sluggish or abnormal pupils) to 5 (normally reactive pupils)

  7. Diameter of the pupil [24 hours, 48 hours, 72 hours]

    In millimeters (pupillometry measure)

  8. Percentage of pupil dilatation [24 hours, 48 hours, 72 hours]

    Pupillometry measure

  9. Latency of pupil dilatation [24 hours, 48 hours, 72 hours]

    In milliseconds (pupillometry measure)

  10. Velocity of pupil dilatation [24 hours, 48 hours, 72 hours]

    In millimeters per second (pupillometry measure)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Admission to the ICU after cardiac arrest

  • Age > 18 years

  • Presenting a Glasgow score of <8 at admission

Exclusion Criteria:
  • Pregnancy

  • Ocular pathology making pupillometry impossible.

  • Patient under guardianship or curatorship

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Central Hospital, Nancy, France

Investigators

  • Principal Investigator: Matthieu Koszutski, Dr, Nancy Teaching Hospital, CHU de Nancy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT04336930
Other Study ID Numbers:
  • 2019PI275
First Posted:
Apr 7, 2020
Last Update Posted:
May 24, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Central Hospital, Nancy, France
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 24, 2021